Frontlight ResearchEarly access
Trial site
Shijiazhuang
- 10running trials
- 6closed trials
The trials here
What the 16 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer3 trials
- Familial hypercholesterolaemia2 trials
- Myasthenia gravis2 trials
- ANCA-associated vasculitis1 trial
- Coronary artery disease1 trial
- Hidradenitis suppurativa1 trial
- Immune thrombocytopenia (ITP)1 trial
- Migraine1 trial
- Multiple sclerosis1 trial
- Psoriasis1 trial
- Stroke1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 37 trials
- Phase 24 trials
- Phase 43 trials
- Status
- Active, not recruiting8 trials
- Completed5 trials
- Recruiting2 trials
- Terminated1 trial
- Lead sponsor
- Novartis Pharmaceuticals16 trials
Running trials
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Hidradenitis suppurativa1 recruiting
Closed trials
Completed
Completed
Completed
Study of Efficacy and Safety of Ofatumumab in Relapsing Multiple Sclerosis (RMS) Patients in China
Terminated
Completed
Study of Efficacy and Safety of Erenumab in Adult Chronic Migraine Patients
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026